乳癌术后辅助放化治疗对远期生存的影响

Effect of Adjuvant Radiotherapy and Chemotherapy on Distal Survival Among Postoperative Breast Cancer

本文回顾总结我院内科１９７７至１９８７年收治９８例Ⅱ、Ⅲ期乳癌术后病人辅助化疗及辅助放化治疗的远期疗效，该组５、１０年生存率７１．４％与４２．９％，较同期手术组Ⅱ、Ⅲ期病人５、１０年生存率６６．４％与２９．６％提高。在Ⅱ期病人中辅助化疗组５、１０年生存率９４．１％与７３．５％明显高于Ⅱ期放化治疗组５、１０年生存率６９．６％与２６．１％。Ⅲ期病人辅助化疗组与辅助放化组生存率相近似。

In this article, we summarize distal survival of 98 patients with Ⅱ、Ⅲ stage postoperative breast cancer who were treated with adjuvant chemotherapy and radiotherapy from 1977 to 1987. The 5-year and 10-year survival rates in our group were 71. 4% and 42. 9%,respectively,and higher then those of 66. 4% and 29. 6% in Ⅱ、Ⅲ stage single operated patients in the some period. Of Ⅱ stage postoperative patients received adjuvant chemotherapy alone,5-year and 10-year survival rates were 94. 1% and 73. 5%,distinctly superior to those of 69. 6% and 26. 2% in Ⅱ stage patients received both adjuvant chemotherapy and radiotherapy.Survival rate of Ⅲ stage patients with single adjuvant chemotherapy group was similar to that of those with both adjuvant chemotherapy and radiotherapy group.